Table 2. Associations between TGFBI expression and clinicopathological factors of patients with ccRCC (based on TCGA-KIRC).
| Characteristics | TGFBI expression | Chi-square/F | P | |
| Low | High | |||
| Stromal score | ||||
| Low | 177 | 88 | 59.781 | <0.001 |
| High | 88 | 177 | ||
| Immune score | ||||
| Low | 166 | 99 | 33.879 | <0.001 |
| High | 99 | 166 | ||
| Age | ||||
| ≤65 | 164 | 169 | 0.202 | 0.653 |
| >65 | 101 | 96 | ||
| Gender | ||||
| Male | 148 | 196 | 19.085 | <0.001 |
| Female | 117 | 69 | ||
| Laterality | ||||
| Left | 122 | 127 | 0.227 | 0.634 |
| Right | 143 | 137 | ||
| NA | 1 | |||
| Grade | ||||
| GX | 4 | 1 | 24.392 | <0.001 |
| G1 | 10 | 4 | ||
| G2 | 125 | 102 | ||
| G3 | 103 | 119 | ||
| G4 | 20 | 55 | ||
| NA | 3 | 0 | ||
| Stage | ||||
| Stage I | 148 | 117 | 11.178 | 0.011 |
| Stage II | 32 | 25 | ||
| Stage III | 53 | 70 | ||
| Stage IV | 32 | 51 | ||
| Discrepancy | ||||
| Cancer status | ||||
| Tumor free | 194 | 160 | 14.169 | <0.001 |
| With tumor | 59 | 101 | ||
| NA | 12 | 4 | ||